GlassScriptPhysician profile
Yury L Bykov
NPI 1376767780
$8,589.08
in general payments reported to CMS, 2019-2025
22 companies · $2,848 in 2025
The $2,848 reported for 2025 was more than what a typical Orthopaedic Trauma provider received nationally (typical 2025 total: $1,227).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $323 · 2020: $85.37 · 2021: $274 · 2022: $1,356 · 2023: $1,002 · 2024: $2,700 · 2025: $2,848.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,223 · Travel and Lodging: $2,217 · Entertainment: $111.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,222.54 |
| Travel and Lodging | $2,217.11 |
| Entertainment | $110.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $3,870.85 | 2019-2025 | Gamma, T2 Alpha, Pelvis II |
| Novus Surgical Consultants | $1,071.24 | 2024-2025 | |
| Depuy Synthes Sales INC. | $704.18 | 2019-2025 | Na, Va-Lcp, Inhance |
| Arthrex, INC. | $585.74 | 2024-2025 | |
| Si-Bone, INC. | $582.38 | 2022-2025 | |
| Curvafix, INC. | $306.00 | 2024-2025 | Curvafix Im Implant |
| Sanara Medtech INC. | $246.78 | 2021-2024 | Celleraterx |
| Globus Medical, INC. | $133.16 | 2023 | Tibial Nail |
| Skeletal Dynamics INC | $126.00 | 2025 | Align, Geminus, Ijs |
| Ferring Pharmaceuticals INC. | $117.83 | 2023-2025 | Euflexxa |
| Kuros Biosciences USA, INC | $110.79 | 2024 | Magnetos |
| Zimmer Biomet Holdings, INC. | $107.35 | 2022 | |
| Amgen INC. | $92.06 | 2023 | Evenity |
| My01 INC. | $91.19 | 2022 | |
| Cerapedics INC. | $88.85 | 2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $88.72 | 2025 | |
| Kerecis Limited | $80.00 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Biocomposites INC | $78.90 | 2024 | |
| Electronic Waveform Lab, INC. | $40.18 | 2025 | |
| Heron Therapeutics, INC. | $30.00 | 2022 | |
| Abbott Laboratories | $21.47 | 2025 | Eterna |
| Endo USA, INC. | $15.41 | 2025 | Xiaflex |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yury Bykov listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.